| European Case Law Identifier: | ECLI:EP:BA:2006:T102302.20060519 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 19 May 2006 | ||||||||
| Case number: | T 1023/02 | ||||||||
| Application number: | 91918320.2 | ||||||||
| IPC class: | A61K 39/12 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Recombinant herpes simplex viruses vaccines and methods | ||||||||
| Applicant name: | Arch Development Corporation | ||||||||
| Opponent name: | University College London The University Court of the University of Glasgow |
||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: | |||||||||
| Keywords: | Added matter (no) - novelty, inventive step, sufficiency of disclosure (yes) | ||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t021023eu1.html
Date retrieved: 17 May 2021
8 references found.
Click X to load a reference inside the current page, click on the title to open in a new page.Case Law Book: II Conditions to be met by an Application
XCLR II A 6.2 Meaning of terms and phrases: "comprising (substantially)", "consisting (essentially) of", "containing"
